Free Trial
NYSE:FNA

Paragon 28 (FNA) Stock Price, News & Analysis

Paragon 28 logo
$10.03 +0.23 (+2.35%)
(As of 12/20/2024 05:31 PM ET)

About Paragon 28 Stock (NYSE:FNA)

Key Stats

Today's Range
$9.63
$10.15
50-Day Range
$4.77
$10.74
52-Week Range
$4.65
$14.79
Volume
1.45 million shs
Average Volume
609,470 shs
Market Capitalization
$839.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.60
Consensus Rating
Buy

Company Overview

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Paragon 28 Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
61st Percentile Overall Score

FNA MarketRank™: 

Paragon 28 scored higher than 61% of companies evaluated by MarketBeat, and ranked 412th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Paragon 28 has received a consensus rating of Buy. The company's average rating score is 3.20, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Paragon 28 has only been the subject of 3 research reports in the past 90 days.

  • Read more about Paragon 28's stock forecast and price target.
  • Earnings Growth

    Earnings for Paragon 28 are expected to grow in the coming year, from ($0.66) to ($0.49) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Paragon 28 is -13.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Paragon 28 is -13.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Paragon 28 has a P/B Ratio of 4.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.15% of the float of Paragon 28 has been sold short.
  • Short Interest Ratio / Days to Cover

    Paragon 28 has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Paragon 28 has recently decreased by 20.58%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Paragon 28 does not currently pay a dividend.

  • Dividend Growth

    Paragon 28 does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.15% of the float of Paragon 28 has been sold short.
  • Short Interest Ratio / Days to Cover

    Paragon 28 has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in Paragon 28 has recently decreased by 20.58%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Paragon 28 has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Paragon 28 this week, compared to 8 articles on an average week.
  • Search Interest

    2 people have searched for FNA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Paragon 28 insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,585,514.00 in company stock.

  • Percentage Held by Insiders

    15.32% of the stock of Paragon 28 is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.57% of the stock of Paragon 28 is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Paragon 28's insider trading history.
Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

FNA Stock News Headlines

AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
Paragon 28 Expands Board with New Independent Director
See More Headlines

FNA Stock Analysis - Frequently Asked Questions

Paragon 28's stock was trading at $12.43 at the start of the year. Since then, FNA shares have decreased by 19.3% and is now trading at $10.03.
View the best growth stocks for 2024 here
.

Paragon 28, Inc. (NYSE:FNA) announced its earnings results on Tuesday, November, 12th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.01. Paragon 28's revenue was up 18.0% compared to the same quarter last year.

Paragon 28 (FNA) raised $125 million in an initial public offering on Friday, October 15th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share. BofA Securities and Piper Sandler served as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

Paragon 28's top institutional investors include Braidwell LP (4.95%), State Street Corp (1.87%), Geode Capital Management LLC (1.16%) and Wellington Management Group LLP (0.83%). Insiders that own company stock include Mvm Partners Llp, B Ag Bird, Mvm Partners, Llc, Albert Dacosta, Frank S Bono, Matthew Jarboe, Lee Rosenthal, Thomas P Schnettler and Kristina Wright.
View institutional ownership trends
.

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Paragon 28 investors own include Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
11/12/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Fax
N/A
Employees
343,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.60
High Stock Price Target
$20.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+55.5%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
5 Analysts

Profitability

Net Income
$-57,530,000.00
Pretax Margin
-26.58%

Debt

Sales & Book Value

Annual Sales
$245.00 million
Book Value
$2.05 per share

Miscellaneous

Free Float
70,894,000
Market Cap
$839.71 million
Optionable
Optionable
Beta
1.52
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NYSE:FNA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners